DE60218064D1 - Neues peptid mit angiotensinkonvertase hemmender wirkung - Google Patents

Neues peptid mit angiotensinkonvertase hemmender wirkung

Info

Publication number
DE60218064D1
DE60218064D1 DE60218064T DE60218064T DE60218064D1 DE 60218064 D1 DE60218064 D1 DE 60218064D1 DE 60218064 T DE60218064 T DE 60218064T DE 60218064 T DE60218064 T DE 60218064T DE 60218064 D1 DE60218064 D1 DE 60218064D1
Authority
DE
Germany
Prior art keywords
inconvertase
angiotin
new peptide
inhibitor effect
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60218064T
Other languages
English (en)
Other versions
DE60218064T2 (de
Inventor
Akio Yamada
Hitoshi Saito
Yasushi Kawaguchi
Eri Inoue
Hiroshi Ochi
Tomoko Ide
Yoshitaka Tamura
Hiroshi Miyakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19167543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60218064(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of DE60218064D1 publication Critical patent/DE60218064D1/de
Application granted granted Critical
Publication of DE60218064T2 publication Critical patent/DE60218064T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE60218064T 2001-11-21 2002-11-21 Neues peptid mit angiotensinkonvertase hemmender wirkung Expired - Lifetime DE60218064T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001355923 2001-11-21
JP2001355923 2001-11-21
PCT/JP2002/012197 WO2003044044A1 (fr) 2001-11-21 2002-11-21 Nouveau peptide exerçant un effet inhibiteur d'angiotensine convertase

Publications (2)

Publication Number Publication Date
DE60218064D1 true DE60218064D1 (de) 2007-03-22
DE60218064T2 DE60218064T2 (de) 2007-11-15

Family

ID=19167543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60218064T Expired - Lifetime DE60218064T2 (de) 2001-11-21 2002-11-21 Neues peptid mit angiotensinkonvertase hemmender wirkung

Country Status (19)

Country Link
US (1) US7022676B2 (de)
EP (1) EP1457498B9 (de)
JP (1) JP3816921B2 (de)
KR (1) KR100615844B1 (de)
CN (1) CN1240711C (de)
AT (1) ATE353336T1 (de)
AU (1) AU2002366037B2 (de)
BR (1) BR0214299A (de)
CA (1) CA2468039C (de)
CY (1) CY1106557T1 (de)
DE (1) DE60218064T2 (de)
DK (1) DK1457498T3 (de)
ES (1) ES2281567T3 (de)
HK (1) HK1076114A1 (de)
MX (1) MXPA04004805A (de)
NO (1) NO328611B1 (de)
NZ (1) NZ533544A (de)
PT (1) PT1457498E (de)
WO (1) WO2003044044A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA87278C2 (ru) 2003-08-01 2009-07-10 Калпис Ко., Лтд. Пептиды, которые биологически не разлагаются; ингибитор ангиотензинпревращающего фермента, лекарственное средство и функциональный пищевой продукт
CN1894273B (zh) * 2003-12-01 2011-01-12 明治乳业株式会社 血管紧张素转化酶抑制肽
CN102304169B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压多肽及其用途
CN102276690B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压功能性多肽及其用途
JP5926363B2 (ja) * 2012-02-22 2016-05-25 森永乳業株式会社 ジペプチジルペプチダーゼ−ｉｖ阻害剤
EP2824110A4 (de) 2012-03-09 2015-12-30 Morinaga Milk Industry Co Ltd Dipeptidylpeptidase-iv-hemmer
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
JP6344796B2 (ja) * 2014-09-30 2018-06-20 森永乳業株式会社 高齢者用アルツハイマー型認知症改善剤
JP2018057346A (ja) * 2016-10-07 2018-04-12 森永乳業株式会社 カゼイン酵素処理物及びその製造方法
CN107337710A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物
CN111093685A (zh) * 2017-09-19 2020-05-01 森永乳业株式会社 用于促进能量消耗的组合物
US20210000129A1 (en) * 2018-02-16 2021-01-07 Morinaga Milk Industry Co., Ltd. Composition for lowering blood pressure and/or reducing neutral fats
JP6589011B2 (ja) * 2018-05-17 2019-10-09 森永乳業株式会社 脳機能障害改善用経口組成物
CN113321719B (zh) * 2021-05-20 2022-03-18 澳优乳业（中国）有限公司 一种寡肽及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07313185A (ja) * 1992-08-20 1995-12-05 Marino Forum 21 ぺプチドの製造方法
JP3040389B2 (ja) * 1999-01-18 2000-05-15 日本合成化学工業株式会社 ペプチドの製造法

Also Published As

Publication number Publication date
MXPA04004805A (es) 2004-08-11
PT1457498E (pt) 2007-05-31
DK1457498T3 (da) 2007-06-04
EP1457498A4 (de) 2005-10-19
ES2281567T3 (es) 2007-10-01
EP1457498B1 (de) 2007-02-07
NO328611B1 (no) 2010-03-29
HK1076114A1 (en) 2006-01-06
KR20050044541A (ko) 2005-05-12
KR100615844B1 (ko) 2006-08-25
CA2468039A1 (en) 2003-05-30
US7022676B2 (en) 2006-04-04
CY1106557T1 (el) 2012-01-25
JPWO2003044044A1 (ja) 2005-03-10
EP1457498A1 (de) 2004-09-15
DE60218064T2 (de) 2007-11-15
CN1612892A (zh) 2005-05-04
US20050004041A1 (en) 2005-01-06
CN1240711C (zh) 2006-02-08
AU2002366037B2 (en) 2005-11-03
EP1457498B9 (de) 2009-09-02
WO2003044044A1 (fr) 2003-05-30
AU2002366037A1 (en) 2003-06-10
NZ533544A (en) 2005-02-25
JP3816921B2 (ja) 2006-08-30
CA2468039C (en) 2011-01-04
ATE353336T1 (de) 2007-02-15
NO20042601L (no) 2004-08-18
BR0214299A (pt) 2004-12-14

Similar Documents

Publication Publication Date Title
HK1076114A1 (en) Novel peptide having angiotensin convertase inhibitory effect
NO20034660D0 (no) Spiropyrazolforbindelser
UY27585A1 (es) Cis - imidazolinas
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
ATE338035T1 (de) 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
ATE310009T1 (de) Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
SE0100903D0 (sv) Compounds
ATE382604T1 (de) Aminosäure-derivate als hiv aspartyl-protease- inhibitoren
DE69808619T2 (de) Prostaglandin-pharmazeutische-zusammensetzungen
TR200002542T2 (tr) Meta-azasiklik amino benzoik asit bileşikleri ve bunların integrin antagonistleri olan türevleri
SE0103710D0 (sv) Compounds
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
BR0114709A (pt) Métodos para a preparação de bifenil isoxazol sulfonamidas
HRP20030653B1 (en) Novel benzoylguanidine salt
ATE349427T1 (de) Tryptaseinhibitoren
BR0312734A (pt) Composto de indolina e uso medicinal do mesmo
ITRM20020370A0 (it) Composto peptido-mimetico contenente la sequenza rgd utile come inibitore delle integrine.
DK1534741T3 (da) Fiberformende peptider i stand til at interagere med selvsamlende peptider
DE50310743D1 (de) Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: TAMURA, YOSHITAKA, ZAMA, KANAGAWA, JP

Inventor name: MIYAKAWA, HIROSHI, ZAMA, KANAGAWA, JP

Inventor name: YAMADA, AKIO, ZAMA, KANAGAWA, JP

Inventor name: SAITO, HITOSHI, ZAMA, KANAGAWA, JP

Inventor name: KAWAGUCHI, YASUSHI, ZAMA, KANAGAWA, JP

Inventor name: OCHI, HIROSHI, ZAMA, KANAGAWA, JP

Inventor name: IDE, TOMOKO, ZAMA, KANAGAWA, JP

Inventor name: INOUE, ERI, ZAMA, KANAGAWA, JP

8363 Opposition against the patent
8365 Fully valid after opposition proceedings